Celiac Vaccine Phase I Trial Finished

New vaccine for celiac disease finished Phase I trial.  The results summary are as follows: 34 test subjects were double blinded to test the safety of the new Nexvax2 vaccine for patients diagnosed with celiac disease.  All patients were HLA-DQ 2 or 8 positive.  In all, 19 subjects received the vaccine.  Three different doses were … Continue reading Celiac Vaccine Phase I Trial Finished